SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-24-012900
Filing Date
2024-06-21
Accepted
2024-06-21 16:48:57
Documents
2
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 3847
2 POA exhibit24-1.txt EX-24.1 2973
  Complete submission text file 0001062993-24-012900.txt   8354
Mailing Address C/O ZENTALIS PHARMACEUTICALS, LLC 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018
Business Address
Blackwell Kimberly (Reporting) CIK: 0001816465 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40498 | Film No.: 241061129

Mailing Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Issuer) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)